PF-Atlas › Clinical Trials › NCT05842499

Substrate abLatIon as Concomitant trEatment for Left Atrial Macroreentrant Tachycardia

Line Set Strategy · Not specified

Registry ID
NCT05842499
Phase
Not specified
Status
Unknown
Drug / intervention
Line Set Strategy
Sponsor
Hospital Universitario 12 de Octubre
Start
2021-06-15

About this trial

Line Set Strategy is evaluated in NCT05842499, a idiopathic pulmonary fibrosis study sponsored by Hospital Universitario 12 de Octubre. Current status: Unknown.

View NCT05842499 on ClinicalTrials.gov →

Explore related

All Line Set Strategy trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT05842499 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.